HighTower Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
HighTower Advisors's RGEN Position: Q3 2026 in Review
HighTower Advisors opened a new position in Repligen (RGEN) in Q3 2026: 1,401 shares worth $269K. The stake represents ﹤0.01% of the portfolio and ranks #3299 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in RGEN as recently as Q1 2026.
HighTower Advisors first reported a position in RGEN in Q3 2017 and has held it in 36 quarters since. The position peaked at $5.15M in Q3 2021. 523 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- HighTower Advisors held 1,401 shares of Repligen worth $269K as of Q3 2026.
- Repligen was a new HighTower Advisors position in Q3 2026.
- Repligen made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3299 holding.
- HighTower Advisors first reported a position in Repligen in Q3 2017 and has held it in 36 quarters since.
- HighTower Advisors's Repligen position peaked at $5.15M in Q3 2021.
- 523 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.